H.C. Wainwright reiterates Can-Fite BioPharma stock rating at buy
We haven't written up this one. Investing.com has the full story — the link below goes straight to it.
Also reported by 1 other outlet
- Immix Biopharma prices $125M stock offering seekingalpha.com